Does possession of apolipoprotein E e{open}4 benefit cognitive function in healthy young adults?

Neuropsychologia

Volumn 49, Issue 7, 2011, Pages 1693-1697

  Bunce, David ^a,b   Anstey, Kaarin J ^b   Burns, Richard ^b   Christensen, Helen ^b   Easteal, Simon ^c  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c Biology and Environment   (Australia)

Author keywords

Age; Antagonistic pleiotropy; APOE; Cognitive function

Indexed keywords

APOLIPOPROTEIN E EPSILON4; APOLIPOPROTEIN E4; GENOMIC DNA; UNCLASSIFIED DRUG;

ADULT; ADULTHOOD; AGE DISTRIBUTION; ALLELE; ARTICLE; COGNITION; COGNITIVE DEFECT; COMMUNITY LIVING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PROTECTION; RESPONSE TIME; TASK PERFORMANCE;

ADULT; AGING; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4; COGNITION; COGNITION DISORDERS; DATA INTERPRETATION, STATISTICAL; DNA; FEMALE; GENE DOSAGE; GENOTYPE; HEALTH STATUS; HUMANS; INDIVIDUALITY; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE; REACTION TIME; YOUNG ADULT;

EID: 79956137927     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2011.02.042     Document Type: Article

References (30)

1. Amieva H., Le Goff M., Millet X., Orgogozo J.M., Peres K., Barberger-Gateau P., et al. Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms. Annals of Neurology 2008, 64(5):492-498.
2. Baddeley A., Emslie H., Nimmo-Smith I. The Spot-The-Word Test 1992, Thames Valley Test Company, Bury St Edmunds, England.
3. Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005, 64(3):501-508.
4. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., et al. Patterns of brain activation in people at risk for Alzheimer's disease. The New England Journal of Medicine 2000, 343(7):450-456.
5. Bunce D., Fratiglioni L., Small B.J., Winblad B., Backman L. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 2004, 63(5):816-821.
6. Christensen H., Batterham P.J., Mackinnon A.J., Jorm A.F., Mack H.A., Mather K.A., et al. The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample. BMC Geriatrics 2008, 8:14.
7. Cohen J. Statistical power analysis for the behavioral sciences 1988, Erlbaum, Hillsdale, NJ. 2nd ed.
8. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P.C., et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics 1994, 7(2):180-184.
9. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California Verbal Learning Test 1987, Psychological Corporation, San Antonio, Texas.
10. Dennis N.A., Browndyke J.N., Stokes J., Need A., Burke J.R., Welsh-Bohmer K.A., et al. Temporal lobe functional activity and connectivity in young adult APOE e4 carriers. Alzheimer's & Dementia 2010, 6(4):303-311.
11. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278(16):1349-1356.
12. Filippini N., MacIntosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(17):7209-7214.
13. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12(3):189-198.
14. Ghebremedhin E., Schultz C., Braak E., Braak H. High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Experimental Neurology 1998, 153(1):152-155.
15. Han S.D., Bondi M.W. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimer's & Dementia 2008, 4(4):251-254.
16. Han S.D., Drake A.I., Cessante L.M., Jak A.J., Houston W.S., Delis D.C., et al. Apolipoprotein E and traumatic brain injury in a military population: Evidence of a neuropsychological compensatory mechanism?. Journal of Neurology, Neurosurgery, and Psychiatry 2007, 78(10):1103-1108.
17. Han S.D., Houston W.S., Jak A.J., Eyler L.T., Nagel B.J., Fleisher A.S., et al. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiology of Aging 2007, 28(2):238-247.
18. Hubacek J.A., Pitha J., Skodova Z., Adamkova V., Lanska V., Poledne R. A possible role of apolipoprotein E polymorphism in predisposition to higher education. Neuropsychobiology 2001, 43(3):200-203.
19. Jorm A.F., Mather K.A., Butterworth P., Anstey K.J., Christensen H., Easteal S. APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology 2007, 21(1):1-8.
20. Keltikangas-Jarvinen L., Raikkonen K., Lehtimaki T. Dependence between apolipoprotein E phenotypes and temperament in children, adolescents, and young adults. Psychosomatic Medicine 1993, 55(2):155-163.
21. Marchant N.L., King S.L., Tabet N., Rusted J.M. Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacology 2010, 35(5):1090-1096.
22. Mondadori C.R., de Quervain D.J., Buchmann A., Mustovic H., Wollmer M.A., Schmidt C.F., et al. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cerebral Cortex 2007, 17(8):1934-1947.
23. Scarmeas N., Habeck C.G., Hilton J., Anderson K.E., Flynn J., Park A., et al. APOE related alterations in cerebral activation even at college age. Journal of Neurology, Neurosurgery, and Psychiatry 2005, 76(10):1440-1444.
24. Schafer J.L., Graham J.W. Missing data: Our view of the state of the art. Psychological Methods 2002, 7(2):147-177.
25. Small B.J., Rosnick C.B., Fratiglioni L., Backman L. Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging 2004, 19(4):592-600.
26. Smith A. Symbol-Digit Modalities Test (SDMT) manual 1982, Western Psychological Services, Los Angeles, CA.
27. Tiffin J., Asher E.J. The Purdue pegboard; norms and studies of reliability and validity. The Journal of Applied Psychology 1948, 32(3):234-247.
28. Wechsler D. Wechsler memory scale-revised manual 1991, The Psychological Corporation, San Antonio, Texas.
29. Williams G. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957, 11:398-411.
30. Yu Y.W., Lin C.H., Chen S.P., Hong C.J., Tsai S.J. Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neuroscience Letters 2000, 294(3):179-181.